AMN HEALTHCARE SERVICES INC·4/A

Jan 30, 10:58 AM ET

Hagan Mark Christopher 4/A

4/A · AMN HEALTHCARE SERVICES INC · Filed Jan 30, 2026

Research Summary

AI-generated summary of this filing

Updated

AMN (AMN) Chief Information & Digital Officer Mark Hagan Receives RSUs

What Happened
Mark Christopher Hagan, AMN Healthcare’s Chief Information and Digital Officer, had Restricted Stock Units (RSUs) vest on January 15, 2026, resulting in the acquisition of 36,828 shares of AMN common stock. To cover tax withholding, 4,139 shares were surrendered at $19.55 per share (total withholding ≈ $80,917), leaving a net of about 32,689 shares. The gross value of the vested shares at $19.55 was about $719,987; net value after withholding was about $639,070. The filing has been amended to correct the reported beneficial ownership (36,828 shares following the transaction).

Key Details

  • Transaction date: January 15, 2026. Price used for tax withholding: $19.55/share.
  • Gross shares vested/awarded (A): 36,828 shares.
  • Shares withheld for taxes (F): 4,139 shares (591 + 926 + 2,622) → cash value ≈ $80,917.
  • Net shares received: ~32,689 shares.
  • Shares beneficially owned after transaction (as amended): 36,828 shares (footnote F10 corrects prior overstatement).
  • Relevant codes: A = award/grant (RSU vesting); M = exercise/conversion of derivative (conversion of RSUs to shares); F = shares withheld for tax liability.
  • Footnotes: RSUs granted under AMN equity plans with multi-year vesting schedules (grants referenced from 2023–2026). The Form 4 was amended to correct an earlier overstatement of derivative securities; the original Form 4 (filed Jan 16) overstated post-transaction beneficial ownership.

Context

  • These were vested RSUs converting into common stock, with shares withheld to satisfy tax obligations (a routine, non-open-market event).
  • This is an award/vesting event rather than a cash purchase or an open-market sale; such vesting reflects compensation and does not by itself signal insider buying conviction.
  • The amendment corrects reported ownership figures; no indication here of late reporting beyond the corrective amendment.

Insider Transaction Report

Form 4/AAmended
Period: 2026-01-15
Hagan Mark Christopher
Chief Information and Digital
Transactions
  • Exercise/Conversion

    Common Stock

    [F1]
    2026-01-15+1,43340,132 total
  • Tax Payment

    Common Stock

    [F2]
    2026-01-15$19.55/sh591$11,55439,541 total
  • Exercise/Conversion

    Common Stock

    [F1]
    2026-01-15+2,24841,789 total
  • Tax Payment

    Common Stock

    [F2]
    2026-01-15$19.55/sh926$18,10340,863 total
  • Exercise/Conversion

    Common Stock

    [F1]
    2026-01-15+6,63247,495 total
  • Tax Payment

    Common Stock

    [F2]
    2026-01-15$19.55/sh2,622$51,26044,873 total
  • Exercise/Conversion

    Restricted Stock Units

    [F3][F4][F5]
    2026-01-151,4330 total
    Common Stock (1,433 underlying)
  • Exercise/Conversion

    Restricted Stock Units

    [F3][F6][F5]
    2026-01-152,2482,317 total
    Common Stock (2,248 underlying)
  • Exercise/Conversion

    Restricted Stock Units

    [F3][F7][F5]
    2026-01-156,63213,467 total
    Common Stock (6,632 underlying)
  • Award

    Restricted Stock Units

    [F8][F9][F5][F10]
    2026-01-15+36,82836,828 total
    Common Stock (36,828 underlying)
Footnotes (10)
  • [F1]Common stock acquired on the vesting of Restricted Stock Units.
  • [F10]Due to an administrative error, the Form 4 filed by the reporting person on January 16, 2026, overstated the amount of derivative securities beneficially owned following the reported transaction by 36,828 shares. This Form 4 is being amended and restated to reflect that, following the reported transaction, 36,828 securities were beneficially owned by reporting person, not 73,656 as previously reported.
  • [F2]Number of shares withheld for tax purposes.
  • [F3]The Restricted Stock Units identified in this row were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each Restricted Stock Unit represents a contingent right to receive one share of AMN Common Stock.
  • [F4]The Restricted Stock Units identified in this row were granted on January 15, 2023 and vest in three tranches on each of the first, second and third anniversaries of the grant date and the grantee's provision of three periods of credited service.
  • [F5]Restricted Stock Units do not have an expiration date.
  • [F6]The Restricted Stock Units identified in this row were granted on January 15, 2024 and vest in three tranches on each of the first, second and third anniversaries of the grant date and the grantee's provision of three periods of credited service.
  • [F7]The Restricted Stock Units set forth in this row were granted on January 15, 2025 and vest in three tranches on each of the first, second, and third anniversaries of the grant date and the grantee's provision of three periods of credited service.
  • [F8]The Restricted Stock Units reflected in this row were granted pursuant to the AMN Healthcare 2025 Equity Plan. Each Restricted Stock Unit represents a contingent right to receive one share of AMN Common Stock.
  • [F9]The Restricted Stock Units set forth in this row were granted on January 15, 2026 and vest in three tranches on each of the first, second, and third anniversaries of the grant date and the grantee's provision of three periods of credited service.
Signature
/s/ Mark C. Hagan|2026-01-29

Documents

1 file
  • 4
    wk-form4a_1769788691.xml

    FORM 4/A